Cannabis Impairment Detection Device Study

Gaize362 enrolled

Overview

The goal of this study is to develop a cannabis impairment detection device in adult cannabis users. The main question\[s\] it aims to answer are: * Is the investigational device accurate and reliable at detecting cannabis impairment? * is the device safe for the collection of eye movement data from cannabis intoxicated individuals? Participants will be administered a series of Drug Recognition Expert Ocular Tests via the Gaize headset following cannabis consumption.

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

362

Conditions

Cannabis Intoxication

Interventions

Cannabis Impairment TestDEVICE

Automated Drug Recognition Expert Ocular Tests administered via VR Headset, includes test for Lack of Smooth Pursuit, Horizontal and Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. Tests are preceded by an automated system calibration process.

Eligibility

Sex: ALLMin age: 19 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults 19, years or older, having given written informed consent to participate in the research trial and certifying that they will not drive for a period of at least 6 hours post discharge. * Having used cannabis at least one time prior * Having access to legal cannabis * Normal or corrected to normal vision using either glasses or contact lenses, or surgery. Exclusion Criteria: * Enrolled in, or participated in another clinical trial within 30 days before the study * Having a prosthetic eye * Blood pressure greater than 160/90 mmHg and heart rate greater than 100 bpm.

Locations (1)

Dicentra

Toronto, Ontario, Canada

Outcomes

Primary Outcomes

Incidence of device/procedure related Adverse Events/Serious Adverse Events during study intervention

Number of participants experiencing complications related to the investigational device (headache, dizziness, nausea, etc.)

Time frame: Immediately after testing.

Secondary Outcomes

Drug Recognition Expert Protocol Eye Test Scores

Correlation between scores at baseline and post cannabis consumption (10 min, 30 min, 60 min, 90 min)

Time frame: up to 90 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.